Investors

Corporate Governance

Corporate Governance

The Board of Directors of Amicus Therapeutics, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
 

Committee Composition

Independent Director Audit and Compliance Committee Compensation and Leadership Committee Nominating and Governance Committee Science and Technology Committee
Lynn D. Bleil Independent Director Compensation and Leadership Committee Nominating and Governance Committee Science and Technology Committee
Bradley L. Campbell
Michael A. Kelly Independent Director Audit and Compliance Committee Science and Technology Committee
Margaret G. McGlynn Independent Director Compensation and Leadership Committee Nominating and Governance Committee
Michael G. Raab Independent Director Nominating and Governance Committee
Eiry W. Roberts Independent Director Compensation and Leadership Committee Science and Technology Committee
Glenn P. Sblendorio Independent Director Audit and Compliance Committee Compensation and Leadership Committee
Craig A. Wheeler Independent Director Audit and Compliance Committee Science and Technology Committee
Burke W. Whitman Independent Director Audit and Compliance Committee Nominating and Governance Committee
= Independent Director = Chairperson = Member = Chairman of the Board